COSCIENS Biopharma Inc. (CSCI) — Financial Flexibility Index
COSCIENS Biopharma Inc. (CSCI) has a Financial Flexibility Index of -0.21x as of June 2025. Free cash flow of $-4.40 Million (operating CF $-4.45 Million minus capex $49.00K) represents 0% of total liabilities ($20.46 Million). Also explore CSCI shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
COSCIENS Biopharma Inc. Financial Flexibility Index (1996–2024)
Historical Financial Flexibility Index trend for COSCIENS Biopharma Inc. across 29 annual periods. See COSCIENS Biopharma Inc. net asset quality index to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for COSCIENS Biopharma Inc. (1996–2024)
Year-by-year free cash flow to debt coverage for COSCIENS Biopharma Inc.. For the full company profile including market capitalisation, see COSCIENS Biopharma Inc. stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.61x | $-13.41 Million | $-14.57 Million | $21.91 Million | ▲ +10.8% |
| 2023 | -0.69x | $-1.86 Million | $-2.58 Million | $2.71 Million | ▼ -152.6% |
| 2022 | 1.31x | $5.24 Million | $5.23 Million | $4.01 Million | ▲ +3.1% |
| 2021 | 1.27x | $3.31 Million | $2.75 Million | $2.61 Million | ▲ +22.7% |
| 2020 | 1.03x | $3.98 Million | $3.49 Million | $3.85 Million | ▲ +480.0% |
| 2019 | 0.18x | $675.30K | $675.29K | $3.79 Million | ▲ +143.3% |
| 2018 | -0.41x | $-636.58K | $-1.56 Million | $1.55 Million | ▼ -138.7% |
| 2017 | 1.06x | $4.45 Million | $1.25 Million | $4.19 Million | ▼ -57.0% |
| 2016 | 2.47x | $7.34 Million | $3.63 Million | $2.97 Million | ▲ +136.3% |
| 2015 | 1.05x | $5.90 Million | $2.87 Million | $5.64 Million | ▼ -13.4% |
| 2014 | 1.21x | $5.82 Million | $1.84 Million | $4.82 Million | ▲ +109.9% |
| 2013 | 0.58x | $2.62 Million | $460.21K | $4.56 Million | ▲ +1659.2% |
| 2012 | 0.03x | $127.37K | $-117.82K | $3.89 Million | ▼ -87.2% |
| 2011 | 0.26x | $914.92K | $791.62K | $3.58 Million | ▲ +57.4% |
| 2010 | 0.16x | $564.50K | $479.50K | $3.47 Million | ▲ +173.4% |
| 2009 | -0.22x | $-875.72K | $-925.47K | $3.96 Million | ▼ -44.2% |
| 2008 | -0.15x | $-658.07K | $-909.41K | $4.29 Million | ▼ -190.2% |
| 2007 | 0.17x | $521.15K | $-1.10 Million | $3.06 Million | ▲ +23.8% |
| 2006 | 0.14x | $207.32K | $140.59K | $1.51 Million | ▲ +187.5% |
| 2005 | -0.16x | $-264.57K | $-368.84K | $1.69 Million | ▼ -165.4% |
| 2004 | 0.24x | $320.33K | $-76.65K | $1.33 Million | ▲ +2.7% |
| 2003 | 0.23x | $157.47K | $54.42K | $673.27K | ▲ +188.0% |
| 2002 | 0.08x | $66.97K | $-57.75K | $824.69K | ▲ +117.1% |
| 2001 | -0.47x | $-450.28K | $-457.45K | $948.90K | ▼ -75.4% |
| 2000 | -0.27x | $-484.37K | $-506.44K | $1.79 Million | ▼ -196.4% |
| 1999 | -0.09x | $-138.09K | $-207.14K | $1.51 Million | ▲ +93.7% |
| 1998 | -1.44x | $-1.49 Million | $-1.62 Million | $1.04 Million | ▼ -140.9% |
| 1997 | 3.51x | $9.08 Million | $-3.14 Million | $2.59 Million | ▲ +766.1% |
| 1996 | 0.41x | $3.14 Million | $-1.39 Million | $7.73 Million | — |